MyAverix Finance
BE · Other
TEKMIRA PHARM (I9DN)
Other
TEKMIRA PHARM (I9DN) is listed on BE in the Other sector. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for I9DN
P/E ratio
18.00
TEKMIRA PHARM (I9DN) — FAQ
What is I9DN's P/E ratio?
The price-to-earnings (P/E) ratio for TEKMIRA PHARM (I9DN) is 18.00 (data as of 2026-03-23).
Does TEKMIRA PHARM pay a dividend?
Dividend yield is not available in the current snapshot for TEKMIRA PHARM (I9DN). Check the MyAverix Finance app for the latest dividend data.
What sector is TEKMIRA PHARM in?
TEKMIRA PHARM (I9DN) is classified in the Other sector.
What exchange is I9DN listed on?
I9DN is listed on BE.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.